
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health Inc. is projecting robust growth in its Integrated Care and BetterHelp segments, with forecasted Integrated Care revenue reaching $1.6136 billion in CY26, reflecting an annual increase of $34 million. The company anticipates a significant rise in insurance revenue for BetterHelp, estimating it will expand from $13 million in CY25 to between $75 million and $90 million in CY26, thus increasing its share of the revenue mix from 1.4% to 9%. Additionally, the Integrated Care segment's adjusted EBITDA is expected to rise to $251.9 million in CY26, demonstrating a year-over-year growth of $12.6 million and highlighting the anticipated strength of the EBITDA margin in the fourth quarter.
Bears say
Teladoc Health's outlook is negatively impacted by anticipated declines in the BetterHelp segment, which is expected to face a $40.5 million adjusted EBITDA headwind in CY26, resulting from a forecasted reduction in membership and low-single-digit growth targets over the next three years. Additionally, the company's revenue growth slowdown, particularly from BetterHelp, has led to a decrease in its valuation multiple, which currently sits well below its long-term average, reflecting heightened financial uncertainty. Furthermore, the shift from fee-based revenue to visit-based structures in the Integrated Care segment, coupled with expected declines in health plan enrollments due to expiring ACA subsidies, may exacerbate revenue fluctuations and hinder overall growth potential.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares